Robust Price Movement and Market Outperformance
On the trading day, Checkpoint Trends Ltd opened with a notable gap up of 5.00%, immediately setting the tone for a bullish session. The stock maintained this elevated level throughout the day, touching an intraday high of Rs.114.26, which also stands as its new 52-week peak. This price represents a remarkable appreciation from its 52-week low of Rs.9.41, underscoring a substantial rally of over 1,100% within the past year.
The stock outperformed its sector peers by 4.54% on the day, highlighting its relative strength within the Pharmaceuticals & Biotechnology industry. This outperformance aligns with the broader market trend, where the Sensex opened 118.50 points higher and traded at 84,975.84, up 0.36%, edging closer to its own 52-week high of 86,159.02, just 1.39% away.
Consistent Gains Fuel Momentum
Checkpoint Trends Ltd has demonstrated sustained upward momentum, registering gains for three consecutive trading sessions. Over this period, the stock delivered a cumulative return of 15.75%, reflecting strong investor confidence and positive market sentiment. The consistent rise has propelled the stock well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a robust technical uptrend.
This technical strength is further supported by the stock’s Mojo Score of 54.0, which recently improved from a previous Sell grade to a Hold rating as of 4 Sep 2025. The upgrade in Mojo Grade indicates a positive shift in the stock’s fundamental and momentum parameters, although it remains in a cautious stance pending further developments.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Market Capitalisation and Sector Context
Checkpoint Trends Ltd holds a Market Cap Grade of 4, reflecting a mid-cap status within the Pharmaceuticals & Biotechnology sector. The sector itself has been buoyant, with small-cap stocks leading the market rally; the BSE Small Cap index gained 0.9% on the same day. This environment has provided a favourable backdrop for Checkpoint Trends Ltd’s price appreciation.
Over the past year, the stock’s performance has been exceptional, delivering a staggering 775.56% return compared to the Sensex’s 8.75% gain over the same period. This divergence highlights the stock’s unique growth trajectory and its ability to capitalise on sectoral and company-specific catalysts.
Technical Indicators Confirm Strength
The stock’s position above all major moving averages is a strong technical signal. Trading above the 200-day moving average is often viewed as a long-term bullish indicator, while the 5-day and 20-day averages reflect short-term momentum. The alignment of these averages, with the stock price consistently higher, suggests sustained buying interest and a positive trend.
Additionally, the stock’s opening gap of 5% on the day of the new high indicates strong demand from the outset of trading, which was maintained throughout the session without any significant price retracement. This price stability at elevated levels is a sign of confidence among market participants.
Checkpoint Trends Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Metrics
As of 31 Dec 2025, Checkpoint Trends Ltd’s stock price stands at Rs.114.26, marking its highest level in over a year and an all-time peak. The stock has gained 5.00% on the day, outperforming its sector by 4.54%. Its Mojo Score of 54.0 and upgraded Mojo Grade to Hold reflect improved fundamentals and momentum. The stock’s market capitalisation and technical indicators further support its current strength.
The broader market context, with the Sensex trading near its own 52-week high and small caps leading gains, complements the stock’s performance. The stock’s remarkable 775.56% return over the past year dwarfs the Sensex’s 8.75% rise, underscoring its exceptional growth within the Pharmaceuticals & Biotechnology sector.
Checkpoint Trends Ltd’s Price Trajectory
From a low of Rs.9.41 in the past 52 weeks to the current high of Rs.114.26, the stock has demonstrated extraordinary appreciation. This trajectory reflects a combination of favourable sector dynamics, company-specific developments, and sustained buying interest. The stock’s ability to maintain gains above key moving averages and its recent upgrade in Mojo Grade indicate a solid foundation for its current valuation.
While the stock’s momentum is evident, its Hold rating suggests a balanced view of its valuation and risk profile. The market’s positive reception on 31 Dec 2025, with a 5% gap up and steady trading at the new high, confirms the stock’s strong position within its sector and the broader market.
Conclusion
Checkpoint Trends Ltd’s achievement of a new 52-week and all-time high at Rs.114.26 marks a significant milestone in its market journey. Supported by strong technical indicators, sectoral tailwinds, and a substantial year-on-year return, the stock has established itself as a notable performer in the Pharmaceuticals & Biotechnology space. Its recent upgrade in Mojo Grade to Hold and sustained gains over multiple sessions reflect a positive shift in its market standing as of the end of 2025.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
